Literature DB >> 23093109

Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading.

Valeria Barresi1, Luca Reggiani Bonetti, Giovanni Branca, Carmela Di Gregorio, Maurizio Ponz de Leon, Giovanni Tuccari.   

Abstract

The most widely used system to define the histological grade of colorectal carcinoma (CRC) is based on the degree of gland formation. This system suffers from significant interobserver variability which may limit its prognostic value and consequently better standardized criteria for the assessment of histological grading of CRC are needed. The present study aims to evaluate and to compare, in a cohort of postsurgical pTNM stage I CRC, conventional histological grading, and a novel grading system based on the number of poorly differentiated clusters of neoplastic cells, in terms of interobserver reproducibility, prognostic significance on progression-free survival, and association with other clinicopathological characteristics. Grading with both systems was performed by two pathologists independently and blinded to the clinicopathological data. Interobserver agreement was higher when grade was assessed by counting poorly differentiated clusters than by assessing the relative proportion of the glandular component. Contrary to conventional grading, the novel system provided significant prognostic information in terms of progression-free survival and was significantly associated with budding, invasive growth, lymphatic invasion, and occult nodal metastases of CRC. In conclusion, our findings suggest that a tumor grading system based on the number of poorly differentiated clusters is more reproducible and provides better prognostic stratification of pTNM stage I CRC patients than conventional grading.

Entities:  

Mesh:

Year:  2012        PMID: 23093109     DOI: 10.1007/s00428-012-1326-8

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  28 in total

1.  THE GRADING AND PROGNOSIS OF CARCINOMA OF THE COLON AND RECTUM.

Authors:  R S Grinnell
Journal:  Ann Surg       Date:  1939-04       Impact factor: 12.969

2.  Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma.

Authors:  Valeria Barresi; Luca Reggiani-Bonetti; Carmela Di Gregorio; Enrica Vitarelli; Maurizio Ponz De Leon; Gaetano Barresi
Journal:  Pathol Res Pract       Date:  2011-07-02       Impact factor: 3.250

3.  Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: prognostic relevance and correlation with nodal micrometastases.

Authors:  Valeria Barresi; Luca Reggiani Bonetti; Enrica Vitarelli; Carmela Di Gregorio; Maurizio Ponz de Leon; Gaetano Barresi
Journal:  Am J Surg Pathol       Date:  2012-01       Impact factor: 6.394

4.  Cancer statistics, 1999.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

5.  Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992-1997.

Authors:  X Cheng; V W Chen; B Steele; B Ruiz; J Fulton; L Liu; S E Carozza; R Greenlee
Journal:  Cancer       Date:  2001-11-15       Impact factor: 6.860

Review 6.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

Authors:  C C Compton; L P Fielding; L J Burgart; B Conley; H S Cooper; S R Hamilton; M E Hammond; D E Henson; R V Hutter; R B Nagle; M L Nielsen; D J Sargent; C R Taylor; M Welton; C Willett
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

7.  Dukes' classification revisited. Findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01).

Authors:  E R Fisher; R Sass; A Palekar; B Fisher; N Wolmark
Journal:  Cancer       Date:  1989-12-01       Impact factor: 6.860

8.  Observer variation in the histological grading of rectal carcinoma.

Authors:  G D Thomas; M F Dixon; N C Smeeton; N S Williams
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

9.  Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines.

Authors:  R Kikuchi; M Takano; K Takagi; N Fujimoto; R Nozaki; T Fujiyoshi; Y Uchida
Journal:  Dis Colon Rectum       Date:  1995-12       Impact factor: 4.585

10.  Genetic diagnosis of lymph-node metastasis in colorectal cancer.

Authors:  N Hayashi; I Ito; A Yanagisawa; Y Kato; S Nakamori; S Imaoka; H Watanabe; M Ogawa; Y Nakamura
Journal:  Lancet       Date:  1995-05-20       Impact factor: 79.321

View more
  24 in total

Review 1.  Neuroendocrine differentiation: The mysterious fellow of colorectal cancer.

Authors:  Britta Kleist; Micaela Poetsch
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

2.  Prognostic relevance of histopathological features in signet ring cell carcinoma of the colorectum.

Authors:  Valeria Barresi; Luca Reggiani Bonetti; Federica Domati; Luigi Baron
Journal:  Virchows Arch       Date:  2016-07-09       Impact factor: 4.064

3.  Evaluation of colon cancer histomorphology: a comparison between formalin and PAXgene tissue fixation by an international ring trial.

Authors:  Sibylle Gündisch; Julia Slotta-Huspenina; Paolo Verderio; Chiara Maura Ciniselli; Sara Pizzamiglio; Christina Schott; Enken Drecoll; Christian Viertler; Kurt Zatloukal; Marcel Kap; Peter Riegman; Irene Esposito; Katja Specht; Gregor Babaryka; Martin Asslaber; Koppany Bodó; Michael den Bakker; Jan den Hollander; Falko Fend; Jens Neumann; Simone Reu; Aurel Perren; Rupert Langer; Alessandro Lugli; Ingrid Becker; Thomas Richter; Gian Kayser; Annette M May; Fatima Carneiro; José Manuel Lopes; Leslie Sobin; Heinz Höfler; Karl-Friedrich Becker
Journal:  Virchows Arch       Date:  2014-08-02       Impact factor: 4.064

Review 4.  Controversies in the pathological assessment of colorectal cancer.

Authors:  Aoife Maguire; Kieran Sheahan
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

5.  Poorly differentiated clusters (PDCs) as a novel histological predictor of nodal metastases in pT1 colorectal cancer.

Authors:  Valeria Barresi; Giovanni Branca; Antonio Ieni; Luca Reggiani Bonetti; Luigi Baron; Stefania Mondello; Giovanni Tuccari
Journal:  Virchows Arch       Date:  2014-04-27       Impact factor: 4.064

6.  Expression patterns of bone morphogenetic protein antagonists in colorectal cancer desmoplastic invasion fronts.

Authors:  George S Karagiannis; Ann Treacy; David Messenger; Andrea Grin; Richard Kirsch; Robert H Riddell; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2014-04-19       Impact factor: 6.603

7.  Novel risk factors for lymph node metastasis in early invasive colorectal cancer: a multi-institution pathology review.

Authors:  Hideki Ueno; Kazuo Hase; Yojiro Hashiguchi; Hideyuki Shimazaki; Shinji Yoshii; Shin-ei Kudo; Masafumi Tanaka; Yoshito Akagi; Takeshi Suto; Shinji Nagata; Keiji Matsuda; Koji Komori; Kazuhiko Yoshimatsu; Yasuhiko Tomita; Shozo Yokoyama; Eiji Shinto; Takahiro Nakamura; Kenichi Sugihara
Journal:  J Gastroenterol       Date:  2013-09-25       Impact factor: 7.527

Review 8.  Prognostic stratification of colorectal cancer patients: current perspectives.

Authors:  Nora I Schneider; Cord Langner
Journal:  Cancer Manag Res       Date:  2014-07-02       Impact factor: 3.989

9.  Clinicopathologic impacts of poorly differentiated cluster-based grading system in colorectal carcinoma.

Authors:  Jeong Won Kim; Mi Kyung Shin; Byung Chun Kim
Journal:  J Korean Med Sci       Date:  2014-12-23       Impact factor: 2.153

10.  Prognostic impact of histological categorisation of epithelial-mesenchymal transition in colorectal cancer.

Authors:  H Ueno; E Shinto; Y Kajiwara; S Fukazawa; H Shimazaki; J Yamamoto; K Hase
Journal:  Br J Cancer       Date:  2014-09-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.